Post

Will smart tech revolutionise drug delivery for ulcerative colitis patients?

Therapies within the ulcerative colitis (UC) space are ever-evolving for the improvement of local, targeted therapy. UC is a chronic …

NextPoint doses first subject in Phase I solid tumour treatment trial

NextPoint Therapeutics has dosed the first subject in a Phase I clinical trial of its therapeutic agent, NPX887, for the …

Polpharma looks to challenge Takeda’s Entyvio in IBD

Netherland-based Polpharma Biologics has released top-line results from the Phase III trial of its biosimilar candidate PB016, showing that the …

Olatec to launch Phase II trial of dapansutrile for Parkinson’s disease

Olatec Therapeutics has received a grant to commence a Phase II clinical trial of dapansutrile to slow down or stop …

Oramed to reinitiate pivotal type 2 diabetes trial after Phase III flop

Oramed Pharmaceuticals has announced it is looking to reinitiate a Phase III trial of its oral insulin candidate in type …